Test Environment
  
X Close Window
This healthcare service has 1 current healthcare service locations.
Northern Alberta Blood And Marrow Transplant Program   at
Cross Cancer Institute
Specialty: Blood and Marrow Transplant
Connect Care Department: EDM CCI BMT
Estimated time to routine appointment: Within 1 month
Alberta Health Services - Edmonton Zone
SERVICE DESCRIPTION
Provides care and support to people requiring cellular therapy.Offers care and support for people having an allogeneic or autologous blood and marrow transplant or immune effector cellular therapy (CAR T-Cell).
Provides care and support to people requiring cellular therapy.Offers care and support for people having an allogeneic or autologous blood and marrow transplant or immune effector cellular therapy (CAR T-Cell).
ELIGIBILITY REQUIREMENTS
Patient must have a form of aggressive Lymphoma.

Patients must also meet the following criteria:
  • No prior adoptive T-cell immunotherapy
  • Clinically stable and expected to remain so through to planned CAR T-cell infusion date with adequate vital organ function and performance status such that patient is expected to tolerate therapy
  • No active CNS disease. Patients with history of CNS disease that has been effectively treated are eligible for CAR T-cell therapy
  • No active uncontrolled hepatitis B, hepatitis C, or HIV infection
  • If prior allogeneic SCT, no evidence of active graft-versus-host-disease or need for ongoing immunosuppression
  • Ineligible for or failed autologous stem cell transplantation (DLBCL patients only)
*Approximate time to CAR T infusion - Within 4-6 weeks

ROUTINE
Allogeneic Transplant
  • Relapsed acute leukemia in remission
  • High cytogenetics risk acute leukemia
  • Acute leukemia requiring >1 cycle chemotherapy to achieve remission
  • CMML-2 or RAEB-2, CML AP or CP2
  • MDS with evidence of transformation Acute leukemia in first complete remission without high-risk cytogenetics
  • Transfusion-dependent MDS
  • Acute leukemia not in remission
  • Lymphoblastic or Burkitt lymphoma
  • Myelofibrosis in transformation
  • Severe aplastic anemia
  • CCL or indolent NHL
  • Hodgkin lymphoma
  • Multiple myeloma
  • Chronic myeloid leukemia, resistant or intolerant to TKI’s
  • Sickle Cell Disease
SEMI URGENT

Autologous Transplant
  • Multiple myeloma
  • Relapsed indolent lymphoma
  • Acute leukemia in remission
  • Relapsed germ cell tumour
Allogeneic Transplant
  • Post Allogeneic Transplant (Day +100) from a transplant site within Canada
Alberta CAR T-Cell Therapy Program

URGENT
Autologous Transplant
  • Lymphoblastic or Burkitt lymphoma
  • Relapsed Hodgkin lymphoma
  • Relapsed aggressive lymphoma
 CAR T-cell Therapy
Alberta CAR T-Cell Therapy Program
At this time, the NABMTP team is accepting only referrals related to adult patients for CAR T-Cell Therapy.

Post Allogeneic Stem Cell Transplant Survivorship Care (Greater than Day +730)
  • Must be greater than two years from time of Allogeneic Stem Cell Transplant
  • Must no longer be on immunosuppression for management of chronic Graft versus Host Disease (GVHD)
Patient must have a form of aggressive Lymphoma.

Patients must also meet the following criteria:
  • No prior adoptive T-cell immunotherapy
  • Clinically stable and expected to remain so through to planned CAR T-cell infusion date with adequate vital organ function and performance status such that patient is expected to tolerate therapy
  • No active CNS disease. Patients with history of CNS disease that has been effectively treated are eligible for CAR T-cell therapy
  • No active uncontrolled hepatitis B, hepatitis C, or HIV infection
  • If prior allogeneic SCT, no evidence of active graft-versus-host-disease or need for ongoing immunosuppression
  • Ineligible for or failed autologous stem cell transplantation (DLBCL patients only)
*Approximate time to CAR T infusion - Within 4-6 weeks

ROUTINE
Allogeneic Transplant
  • Relapsed acute leukemia in remission
  • High cytogenetics risk acute leukemia
  • Acute leukemia requiring >1 cycle chemotherapy to achieve remission
  • CMML-2 or RAEB-2, CML AP or CP2
  • MDS with evidence of transformation Acute leukemia in first complete remission without high-risk cytogenetics
  • Transfusion-dependent MDS
  • Acute leukemia not in remission
  • Lymphoblastic or Burkitt lymphoma
  • Myelofibrosis in transformation
  • Severe aplastic anemia
  • CCL or indolent NHL
  • Hodgkin lymphoma
  • Multiple myeloma
  • Chronic myeloid leukemia, resistant or intolerant to TKI’s
  • Sickle Cell Disease
SEMI URGENT

Autologous Transplant
  • Multiple myeloma
  • Relapsed indolent lymphoma
  • Acute leukemia in remission
  • Relapsed germ cell tumour
Allogeneic Transplant
  • Post Allogeneic Transplant (Day +100) from a transplant site within Canada
Alberta CAR T-Cell Therapy Program

URGENT
Autologous Transplant
  • Lymphoblastic or Burkitt lymphoma
  • Relapsed Hodgkin lymphoma
  • Relapsed aggressive lymphoma
 CAR T-cell Therapy
Alberta CAR T-Cell Therapy Program
At this time, the NABMTP team is accepting only referrals related to adult patients for CAR T-Cell Therapy.

Post Allogeneic Stem Cell Transplant Survivorship Care (Greater than Day +730)
  • Must be greater than two years from time of Allogeneic Stem Cell Transplant
  • Must no longer be on immunosuppression for management of chronic Graft versus Host Disease (GVHD)
Referral instructions for primary care, community care, private
providers etc. who do not send referrals via Connect Care. 
REFERRAL PROCESS - FOR NON-CONNECT CARE USERS
If connect care referral is not possible, complete the referral form and fax it to the service using the contact information in this profile.
If connect care referral is not possible, complete the referral form and fax it to the service using the contact information in this profile.
REFERRAL PROCESS - FOR CONNECT CARE USERS
Send an Internal Referral using the Ambulatory Referral Order to Blood and Marrow Transplant, type EDM CCI BMT in the “To Department” section and complete order. 
Send an Internal Referral using the Ambulatory Referral Order to Blood and Marrow Transplant, type EDM CCI BMT in the “To Department” section and complete order. 
ADDITIONAL SERVICE DETAILS
For Allogeneic BMT referrals, unless special considerations (HLA typing only or consult only) are selected it will be considered a full referral as indicated by cell source.
For Allogeneic BMT referrals routine priority will be automatic and further prioritization will be determined by TBCC BMT triage physician.
For Allogeneic BMT referrals, unless special considerations (HLA typing only or consult only) are selected it will be considered a full referral as indicated by cell source.
For Allogeneic BMT referrals routine priority will be automatic and further prioritization will be determined by TBCC BMT triage physician.
COMMUNICATION PROCESS
  • Referral receipt to referring source within 7 days.
  • Acceptance via appointment details or wait list status letter to referring source and patient within 14 days.
  • Appointment outcome to referral source within 30 days.
 
PHONE
780-432-8677
FAX
780-989-4343
REFERRAL FAX
780-989-4343
REFERRAL FORM
CLICK + TO VIEW REFERRAL GUIDELINES
+-
Routine Reason for Referral
Access Targets convey the clinically appropriate timeframe patients should be seen within, by reason for referral and priority level.
Access Target
Required Information/Investigations
Investigation Timing
Additional Details
+-
Allogeneic transplantation
Medication list (dose, frequency, route)
 
Current
Summary of medical and treatment history
 
Current
Bone marrow reports
 
Current
Chemotherapy records (include induction, consolidation and intrathecal)
 
Current
HLA High Resolution Typing (must be performed within the last two years), CMV IgG, ABO Blood Group and Rh Antibody Screen, HLA platelet antibody investigation (applicable for any recipient with possibility of a mismatched donor including haploidentical donor)
 
Current
Pathology Reports
 
Current
Race: If patient's parents are from more than one of the following groups, indicate all) i.e. Caucasian/White; Black; East Indian; Asian/Pacific Islander; Hispanic; Native North American; Unknown; Other - please indicate
 
Current
Radiation therapy records
 
Current
Radiology reports (CT, PET, CXR, u/s, echo etc)
 
Current
Recent blood work (hematology, ABO Blood group, Rh Antibody Screen, coagulation, chemistry and virology, including CMV IgG serology). HLA platelet antibody investigan (LAB6067).
 
Current
Recipient HLS typing (Bone Marrow Recipient Typing ¿ High Resolution [LAB6050] and Bone Marrow Recipient Typing ¿ Verification [LAB6055], which must be ordered for at least one day after after the high resolution typing/with next blood draw.
 
Current
Summary of factors that may affect consultation/care (e.g. primary language spoken, psychological status, ability to travel, finances)
 
Current
+-
Autologous transplantation
Medication list (dose, frequency, route)
 
Current
Summary of medical and treatment history
 
Current
Bone marrow reports
 
Current
Chemotherapy records (include induction, consolidation and intrathecal)
 
Current
LDH
 
At diagnosis and latest results
Pathology Reports
 
Current
Radiation therapy records
 
Current
Radiology reports (CT, PET, CXR, u/s, echo etc)
 
Current
Recent blood work (include hematology, coagulation, chemistry, and virology
 
Current
Summary of factors that may affect consultation/care (e.g. primary language spoken, psychological status, ability to travel, finances)
 
Current
See Routine Referral Process for ABMTP Referral Triage Guidelines
+-
Consultation
Medication list (dose, frequency, route)
 
Current
Summary of medical and treatment history
 
Current
Bone Marrow reports
 
Current
Pathology Reports
 
Current
Radiology reports (CT, PET, CXR, u/s, echo etc.)
 
Current
Recent blood work (include hematology, coagulation, chemistry, and virology)
 
Current
Summary of factors that may affect consultation/care (e.g. primary language spoken, psychological status, ability to travel, finances)
 
Current
Treatment history (chemotherapy and radiation records - if applicable)
 
Current
CONSULTATION ONLY
+-
HLA tissue typing
Medication list (dose, frequency, route)
 
Current
Summary of medical and treatment history
 
Current
Summary of factors that may affect consultation/care (e.g. primary language spoken, psychological status, ability to travel, finances
 
Current
Referrals to NABMTP for HLA typing should be for the purpose of allogeneic transplant investigations. NABMTP does not accept referrals for HLA typing for general purposes or for investigations surrounding sibling typing for patients not under care of a medical oncologist/hematologist associated with an accredited transplant centre.
+-
History of allogeneic transplantation of stem cell
Medication list (dose, frequency, route)
 
Current
Summary of medical and treatment history
 
Current
PATIENT APPOINTMENT INFORMATION
Email
Print
 
MISSED APPOINTMENT GUIDELINES
If you are unable to attend a scheduled appointment, please contact the clinic a minimum of 48 hours in advance.
If you are unable to attend a scheduled appointment, please contact the clinic a minimum of 48 hours in advance.
 
HOURS OF OPERATION
Monday: 8:00 am - 4:00 pm
Tuesday: 8:00 am - 4:00 pm
Wednesday: 8:00 am - 4:00 pm
Thursday: 8:00 am - 4:00 pm
Friday: 8:00 am - 4:00 pm
   
 
ADDRESS
11560 University Avenue
Edmonton Alberta
T6G 1Z2
PATIENT APPOINTMENT INSTRUCTIONS
 
DIRECTIONS
Cross Cancer Institute is located in Edmonton and is off of University Ave between 115 Street NW and 117th Street NW.
Cross Cancer Institute is located in Edmonton and is off of University Ave between 115 Street NW and 117th Street NW.
 
PHONE
780-432-8677
 
PARKING INSTRUCTIONS
Rates apply 24 hours per day, and are in effect for all public parkers, including those with provincially issued placards for persons with disabilities.
Paystations accept Canadian coins, Canadian bills or credit card (Visa, MasterCard, and American Express).
Parking Office and Kiosk accept payment by cash, credit card, debit or cheque.
Rates apply 24 hours per day, and are in effect for all public parkers, including those with provincially issued placards for persons with disabilities.
Paystations accept Canadian coins, Canadian bills or credit card (Visa, MasterCard, and American Express).
Parking Office and Kiosk accept payment by cash, credit card, debit or cheque.
 
EMAIL
VIRTUAL APPOINTMENT INFORMATION
 
 
WHEELCHAIR ACCESSIBILITY
Yes

The primary purpose of the All Locations list is to let the user easily access any location of a healthcare service without going back to the main search screen.

The locations listed have 3 background colors:
  • Green means the healthcare service@location has referral information attached to it.
  • Brown means the healthcare service@location never had referral information attached to it, or it has unpublished referral information.
  • Red means
    • IA changed the healthcare service@location's status to something other than Current
    • It was deleted if it is an ARD healthcare service@location.
Green  and Brown are always at the top of the list. These are the Healthcare Service@Locations with the status of Current.
The Red list at the bottom consists of non-current Healthcare Service@locations that once had Published referral information in the ARD.
If the referral information was never published in ARD the Healthcare Service@location will not show in the Red list.

The secondary purpose of the All Locations list is to allow ARD Administrators to recover (copy) referral information from the non-current Healthcare Service@Locations to ones that are current.

Common Scenario:
A Healthcare Service moves from one location to another. In this case the IA Healthcare Service@Location record will be made defunct (non-current) and a new Healthcare Service@Location record will be created with a current status. In this scenario the captured referral guidelines in ARD can become "orphaned" as they are not attached to any current IA healthcare service.

Categories of non-current or orphaned referral guidelines: INDIVIDUAL and COMMON.
The REFERRAL GUIDELINES section of the profile has the prefix INDIVIDUAL or COMMON to help you choose the method below when transferring referral guidelines from a non-current Healthcare Service@Location to a current healthcare service@location.

Individual referral process
  1. Click on a non-current (Red) Healthcare Service@Location at the bottom of the All Locations list.
  2. The non-current referral info is displayed with the link Copy this Referral Process to another Healthcare Service@Location link on the upper right hand corner. Click on the copy link.
  3. Choose a current location (Green or Brown) from the All Locations list. This will be the Healthcare Service@Location you are pasting the referral info into.
  4. The system will display the Edit Referral Info screen populated with the referral info from the non-current Healthcare Service@Location you viewed in the first step.
  5. Click Save and the referral info is transferred from the non-current Healthcare Service@Location to the current one.
  6. Repeat these steps for each Healthcare Service@Location that needs attention.

Common referral process - 2 sub cases.
Case 1: At least 1 current Healthcare Service@Location with common referral info is with current status for this healthcare service; One or more Healthcare Healthcare Service@Locations where replaced by new one.
  1. Click on any current Healthcare Service@Location whether it has referral info (Green) or not (Brown).
  2. The healthcare service location opens in the Edit Referral Info screen populated with the current common referral info.
  3. Save it. 
  4. All locations will be updated with the common referral information, including all the locations that don't have referral info yet (Brown). The non-current referrals (Red) will also be updated.
Case 2:  All Healthcare Healthcare Service@Locations for a healthcare service are set to a non-current status and replaced by new ones. In this case there is no current additional referral info to copy from, so the only alternative is to pick up the non-current common referral process (Red). Follow the steps described in the section Individual Referral Process above to copy/paste the non-current common referral info to the current healthcare service locations.
Generally we want to replicate current common referral info to new or replaced healthcare service locations. We only resort to copying non-current common referral info if there is no other option.

Remember: Some fields can be location specific with the common referral process:
Parking Instructions, Directions, Parking Map, Wait Time, Referral Phone or Referral Fax.
To update these items you have to edit each Healthcare Service@Location separately.

ADDITONAL NOTES:
  • The info icon after the All Locations drop down will be visible to ARD Administrators.
  • The system doesn't allow you to copy referral information from one non-current Healthcare Service@Location to another.

 

About Us
Terms of Use
Privacy Statement
Disclaimer
ARD Partners
Search Tips
Back to top
FAQ
Contact Us
V6.5